Document is current
Any future updates will be listed below
-
Authors
D’Almeida Preto, Daniel
Baston, Mariana Toledo
Geraige, Camilla Centurion
Augusto, Sarah Bertazzi
de Oliveira, Marco Antonio
Mamere, Augusto Elias
Pinto, Gustavo Dix Junqueira
Dias, Josiane Mourão
De Marchi, Pedro Rafael Martins
Paiva, Bianca Sakamoto Ribeiro
Paiva, Carlos Eduardo http://orcid.org/0000-0002-7934-1451
-
Funding
Funding for this research was provided by:
AferBio Bioalimentos Ltda (NA)
- License Information
-
More Information
Article History
Received: 24 October 2018
Accepted: 11 April 2019
First Online: 25 April 2019
Ethics approval and consent to participate
: The present study was developed according to the norms of Resolution CNS 466/12 (Brazilian National Health Council) and was approved by the Research Ethics Committee of the Barretos Cancer Hospital (n° 2.395.325). This trial is registered withExternalRef removed, NCT03469063. All individuals complying with the inclusion criteria will be invited to participate in the study by a trained research coordinator from the Researcher Support Cencer of the Barretos Cancer Hospital. Each participant will voluntarily sign an Informed Consent Form (ICF). This study will be carried out in accordance with International Conference on Harmonization Good Clinical Practice (ICH-GCP). Every amendment in the research protocol will be first submitted to Research Ethics Committee approval. To avoid breaking data confidentiality only some of the authors (CEP, BSRP, and MAO) will have access to the final study database, which will be typed into online REDCap with restrictive access passwords.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
